204840 Stock Chart & Stats
₩814.00
₩0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range₩778.00 - ₩1,330.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)124.82K
Market Cap
₩63.12B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding77,549,000
10 Day Avg. Volume163,667
30 Day Avg. Volume124,819
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
204840 FAQ
What was GL Pharm Tech Corp.’s price range in the past 12 months?
GL Pharm Tech Corp. lowest stock price was ₩778.00 and its highest was ₩1330.00 in the past 12 months.
What is GL Pharm Tech Corp.’s market cap?
GL Pharm Tech Corp.’s market cap is ₩63.12B.
When is GL Pharm Tech Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GL Pharm Tech Corp.’s earnings last quarter?
GL Pharm Tech Corp. released its earnings results on May 13, 2026. The company reported -₩1.547 earnings per share for the quarter, missing the consensus estimate of N/A by -₩1.547.
Is GL Pharm Tech Corp. overvalued?
According to Wall Street analysts GL Pharm Tech Corp.’s price is currently Undervalued.
Does GL Pharm Tech Corp. pay dividends?
GL Pharm Tech Corp. does not currently pay dividends.
What is GL Pharm Tech Corp.’s EPS estimate?
GL Pharm Tech Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GL Pharm Tech Corp. have?
GL Pharm Tech Corp. has 77,549,000 shares outstanding.
What happened to GL Pharm Tech Corp.’s price movement after its last earnings report?
GL Pharm Tech Corp. reported an EPS of -₩1.547 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.275%.
Which hedge fund is a major shareholder of GL Pharm Tech Corp.?
Currently, no hedge funds are holding shares in KR:204840
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
KUKJE PHARMA Co., Ltd.
―
CTC Bio Inc.
―
PanGen Biotech, Inc.
―
Aptamer Sciences, Inc.
―
KoBioLabs, Inc.
―